The speakers discuss GLP-1 drugs like Ozempic for weight loss and diabetes management. One speaker acknowledges the potential benefits for morbidly obese individuals with existing health conditions, but also mentions the potential side-effects and the possibility for compounding the GLP-1 drugs at lower doses, which may provide a good cost-benefit analysis.